ARCK

Arbor Rapha Capital Bioholdings Corp. I [ARCK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ARCK Stock Summary

In the News

ARCK Financial details

Company Rating
-
Market Cap
256.59M
Income
-445.62B
Revenue
1.05M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
246.78
P/B
-21.98
P/C
-
P/FCF
-655.12
Quick Ratio
1.14
Current Ratio
1.65
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-20.67K
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
230.21%
EPS Q/Q
-490.38%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-248696%
ROE
4868537%
ROC
-2497.73%
Gross Margin
100%
Oper. Margin
-42857749%
Profit Margin
-42857764%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.96-15.5896
52W High
-20.67%
52W Low
+32.22%
RSI
-
Rel Volume
-
Avg Volume
18.66K
Volume
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-13.27%
-
-
-
-
Beta
-
-
-
Volatility
0.79%, 0.79%
Prev Close
0%
Price
11.9
Change
-8.46%

Something similar

Top by Market Cap
AMZ.DE
JPM
META
M&M.NS
1YD.DE
Same Sector
CMO.PA
MNBO
RYOIX
ASCTX
QDVL.DE
Check Those
TRACX
EDTXW
1184.HK
SUNL
3630.TWO
Similar Market Cap
ADTN
FMCLX
FSNB
ASG
LSSCX

Company Profile

Financial Services Shell Companies
  • Volume Average 18.66K
  • Market Capitalization 256.59M
  • CEO Mr. Ivan Paul Kaufman
  • Headquarters Uniondale,NY,US
  • IPO Date 2011-01-28
  • Website https://www.arcbiocorp.com

Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York.